We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
-4.92%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.5M
AUM Growth
-$15.2M
Cap. Flow
-$7.59M
Cap. Flow %
-10.61%
Top 10 Hldgs %
20.8%
Holding
1,384
New
165
Increased
315
Reduced
364
Closed
228

Top Buys

Rank Stock Value
1
SONN
Sonnet BioTherapeutics
SONN
+$1.18M
2
GE icon
GE Aerospace
GE
+$582K
3
CBM
Cambrex Corporation
CBM
+$524K
4
WFM
Whole Foods Market Inc
WFM
+$467K
5
CPSS icon
Consumer Portfolio Services
CPSS
+$463K

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$2M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$1.23M
3
IWC icon
iShares Micro-Cap ETF
IWC
+$1.17M
4
PFE icon
Pfizer
PFE
+$1.1M
5
VV icon
Vanguard Large-Cap ETF
VV
+$957K

Sector Composition

Rank Sector Weight
1 Technology 15.2%
2 Real Estate 11.29%
3 Healthcare 10.98%
4 Industrials 10.7%
5 Financials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VWO icon
276
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$47K 0.07%
1,430
+92
+7% +$3.34K
WDC icon
277
Western Digital
WDC
$179B
$47K 0.07%
777
+170
+28% +$10.2K
COF icon
278
Capital One
COF
$124B
$46K 0.06%
636
-371
-37% -$29.8K
RSG icon
279
Republic Services
RSG
$66.7B
$46K 0.06%
1,125
– –
VRSK icon
280
Verisk Analytics
VRSK
$26.4B
$46K 0.06%
617
-32
-5% -$2.39K
AMN icon
281
AMN Healthcare
AMN
$1.28B
$45K 0.06%
1,500
-750
-33% -$24.8K
TOVX icon
282
Theriva Biologics
TOVX
$10.2M
$45K 0.06%
2
– –
RAD
283
DELISTED
Rite Aid Corporation
RAD
$45K 0.06%
373
-236
-39% -$39.3K
CTSH icon
284
Cognizant
CTSH
$21.5B
$44K 0.06%
701
-132
-16% -$8.29K
GSK icon
285
GSK
GSK
$103B
$44K 0.06%
920
+216
+31% +$11.2K
HIG icon
286
Hartford Financial Services
HIG
$38.5B
$44K 0.06%
953
+70
+8% +$3.23K
MAS icon
287
Masco
MAS
$16B
$44K 0.06%
1,737
-641
-27% -$16.4K
INFN
288
DELISTED
Infinera Corporation Common Stock
INFN
$44K 0.06%
2,250
-42,450
-95% -$925K
CACB
289
DELISTED
Cascade Bancorp
CACB
$44K 0.06%
+8,100
New +$43.3K
SSRG
290
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
$44K 0.06%
+4,900
New +$42.1K
EFA icon
291
iShares MSCI EAFE ETF
EFA
$76.4B
$43K 0.06%
749
– –
GD icon
292
General Dynamics
GD
$105B
$43K 0.06%
313
+25
+9% +$3.62K
IWN icon
293
iShares Russell 2000 Value ETF
IWN
$14.4B
$43K 0.06%
480
– –
VHT icon
294
Vanguard Health Care ETF
VHT
$18.2B
$43K 0.06%
353
– –
AKRX
295
DELISTED
Akorn Inc
AKRX
$43K 0.06%
1,515
+84
+6% +$3.47K
EPAM icon
296
EPAM Systems
EPAM
$4.69B
$42K 0.06%
567
-66
-10% -$4.76K
RJF icon
297
Raymond James Financial
RJF
$32.5B
$42K 0.06%
1,280
-88
-6% -$3.26K
INFI
298
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$42K 0.06%
5,000
– –
HAIN icon
299
Hain Celestial
HAIN
$47.8M
$41K 0.06%
787
+98
+14% +$6.2K
PYPL icon
300
PayPal
PYPL
$49.5B
$41K 0.06%
+1,329
New +$47.6K
10 11
12
13 14

Similar funds

PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
LA
Lakeside Advisors Seattle, Washington $150M AUM 14.73% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
GWA
Genesis Wealth Advisors Braintree, Massachusetts $150M AUM 15.35% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
E
Evansbrook Bolingbrook, Illinois $150M AUM

Thompson Davis & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Thompson Davis & Co held 1,384 positions worth $71.5M, down 18% from $86.7M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Thompson Davis & Co withdrew a net $7.59M in Q3 2015, closing 228 positions and reducing 364 holdings. Its most notable exit was TRADE STREET RESIDENTIAL, INC. COMMON STOCK, an estimated $536K position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Thompson Davis & Co opened a new position in Sonnet BioTherapeutics worth $396K.

  • Thompson Davis & Co's largest Q3 2015 buy was Sonnet BioTherapeutics: 1 share worth $396K.
  • Thompson Davis & Co added most to GE Aerospace in Q3 2015, an estimated $582K increase.
  • Thompson Davis & Co's biggest Q3 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $2M.
  • Thompson Davis & Co fully exited TRADE STREET RESIDENTIAL, INC. COMMON STOCK in Q3 2015, selling an estimated $536K.
  • Thompson Davis & Co's ten largest holdings make up 21% of its $71.5M portfolio in Q3 2015.
  • Thompson Davis & Co opened 165 new positions and closed 228 in Q3 2015.
  • Thompson Davis & Co's portfolio value fell 18% quarter-over-quarter to $71.5M.

Based on Thompson Davis & Co's 13F filing for Q3 2015, filed 30 Oct 2015.